Dr. Lal PathLabs' (NSE:LALPATHLAB, BOM:539524) consolidated attributable profit rose to 1.32 billion Indian rupees in the fiscal first quarter ended June 30, against 1.06 billion rupees a year ago.
Earnings per share came in at 15.85 rupees compared with 12.76 rupees a year earlier, the diagnostics services provider said in a filing to the Indian bourses on Thursday.
Revenue from operations in fiscal Q1 also increased to 6.70 billion rupees from 6.02 billion rupees a year earlier.
The company's shares were up over 1% in recent trade.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。